Legend Biotech Corporation (FRA:9LB)
23.80
-0.20 (-0.83%)
At close: Nov 28, 2025
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €4.26 billion as of December 1, 2025. Its market cap has decreased by -38.62% in one year.
Market Cap
4.26B
Enterprise Value
3.76B
Revenue
774.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€23.80
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from 4.23B to 4.26B, an increase of 0.83%. That is a compound annual growth rate of 0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 4.41B | -23.45% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | 3.05B | -27.80% |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |